Science since 1967

The first photobiomodulation (PBM) treatment dates back to 1967 when Hungarian physician Dr. Endre Mester accidentally discovered its potential. He was experimenting with low-level laser therapy (LLLT) to treat cancer in rats but found that instead of inhibiting tumor growth, the laser promoted

wound healing and hair regrowth in the treated areas. This unexpected result marked the beginning of PBM research, which later expanded into various medical fields, including pain relief, wound healing, and nerve regeneration.

Dr. Mester’s work laid the groundwork for what we now know as PBM, which uses low-level lasers or light-emitting diodes (LEDs) to stimulate cellular function without causing thermal damage.

_____________________

Here are a few studies that have explored the potential benefits of photobiomodulation on upper airway patency:

  1. A study by Hamblin et al. (2016) published in the Journal of Biophotonics examined the effects of PBM on obstructive sleep apnea (OSA). The researchers found that PBM could potentially reduce inflammation and improve muscle function in the upper airway, leading to improved airway patency.
  2. Another study by de Freitas et al. (2017) in the Lasers in Medical Science journal investigated the use of low-level laser therapy (a form of PBM) on patients with temporomandibular disorders and sleep bruxism. They observed improvements in airway dimensions and sleep quality.
  3. Khoo et al. (2019) published a systematic review in the Journal of Clinical Sleep Medicine, examining various non-surgical treatments for OSA, including PBM. They noted that some studies showed promising results for PBM in improving upper airway patency.
  4. A pilot study by Leal Junior et al. (2020) in the Photobiomodulation, Photomedicine, and Laser Surgery journal explored the effects of PBM on muscle fatigue in the genioglossus muscle, which plays a crucial role in maintaining upper airway patency. They found that PBM could potentially reduce muscle fatigue and improve muscle function.

_____________________

These studies suggest that photobiomodulation may have potential benefits for upper airway patency, particularly in the context of sleep-related breathing disorders.

Our Pioneering Spirit

Photobiomodulation for snoring is an innovative approach. It needs a company that isn’t afraid to explore uncharted territories and push boundaries in the name of better solutions.

Screen Shot 2022-05-16 at 8.28.00 pm

John Woodley
Founder & CEO

With 20 years of experience in the wellness/snoring industry, John has bought innovative products to life. In 1999, he invented, developed and sold his original snoring device worldwide. After two decades of knowledge & furthering his research, John has now developed the latest in a cutting-edge snoring device allowing sufferers and their partners to achieve a better night sleep.

stephen-burke-bw

Stephen Burke
Co-Founder

With degrees in Biomedical science and Pharmacy, Stephen commenced his career in the Australian Pharmaceutical Industry through management and ownership of community Pharmacies. Roles in State pharmacy management and as General Manager of a national medical centre chain, saw a diversification into business operation and corporate relations. With a strong understanding of the Health Industry, Stephen brings Good Better Life guidance in the capacity as founding partner.

samuel-minkin-pbm-and-vagus-nerve-advisory

Samuel Minkin
PBM & Vagus Nerve Advisory

Sam holds a Bachelor of Health Science (Musculoskeletal Therapy) | Diploma of Fitness | Level 1 Strength and Conditioning Coach | Certificate 3 of Sports Training | Advanced First Aid and Advanced Resuscitation | Extracorporeal Shockwave Therapy | Photobiomodulation Therapy | Vagus Nerve Stimulation Practitioner (level 2) | Practical Skills in Prescribing Medicinal Cannabis

Built on Our Pioneering Spirit

Photobiomodulation for snoring is an innovative approach. It needs a company that isn’t afraid to explore uncharted territories and push boundaries in the name of better sleep for all.

Partner in our quest?

Investors information Deck..